Natamycin Ocular Delivery: Challenges and Advancements in Ocular Therapeutics
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Natamycin Ocular Delivery: Challenges and Advancements in Ocular Therapeutics ; volume:40 ; number:8 ; day:8 ; month:6 ; year:2023 ; pages:3332-3359 ; date:8.2023
Advances in therapy ; 40, Heft 8 (8.6.2023), 3332-3359, 8.2023
- Urheber
-
Mascarenhas, Mabel
Chaudhari, Pinal
Lewis, Shaila A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-023-02541-x
- URN
-
urn:nbn:de:101:1-2023101308121121803623
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
09.11.20052005, 14:33 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mascarenhas, Mabel
- Chaudhari, Pinal
- Lewis, Shaila A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Revolutionizing ocular drug delivery: recent advancements in in situ gel technology
Microneedle-based ocular drug delivery systems – recent advances and challenges
Recent Perspectives in Ocular Drug Delivery
Ocular Drug Delivery: a Comprehensive Review
Ocular sarcoidosis: clinical experience and recent pathogenetic and therapeutic advancements
Light-responsive biomaterials for ocular drug delivery
Nanoparticles for drug delivery to ocular neovascularizations
Ocular tuberculosis masquerading as atypical ocular toxoplasmosis
Ocular infections
Ocular oncology
Ocular tumors
Ocular Nanomedicine
Revolutionizing ocular drug delivery: recent advancements in in situ gel technology
Microneedle-based ocular drug delivery systems – recent advances and challenges
Recent Perspectives in Ocular Drug Delivery
Ocular Drug Delivery: a Comprehensive Review
Ocular sarcoidosis: clinical experience and recent pathogenetic and therapeutic advancements
Light-responsive biomaterials for ocular drug delivery
Nanoparticles for drug delivery to ocular neovascularizations
Ocular tuberculosis masquerading as atypical ocular toxoplasmosis
Ocular infections
Ocular oncology
Ocular tumors
Ocular Nanomedicine
Revolutionizing ocular drug delivery: recent advancements in in situ gel technology
Microneedle-based ocular drug delivery systems – recent advances and challenges
Recent Perspectives in Ocular Drug Delivery
Ocular Drug Delivery: a Comprehensive Review
Ocular sarcoidosis: clinical experience and recent pathogenetic and therapeutic advancements
Light-responsive biomaterials for ocular drug delivery
Nanoparticles for drug delivery to ocular neovascularizations
Ocular tuberculosis masquerading as atypical ocular toxoplasmosis
Ocular infections
Ocular oncology
Ocular tumors